Portola Pharmaceuticals sinks on news of public offering


Portola Pharmaceuticals (PTLA -7.1%) falls sharply after announcing a $100M public offering.

The deal will reportedly include shares from selling stockholders.

The company intends to use a portion of the proceeds to "support the pursuit of an accelerated approval process for Andexanet alfa." (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs